Becton, Dickinson and Co. | BDX - Market Capitalization

Stock Price
152.14
Daily Change
-2.71 -1.75%
Monthly
-3.87%
Yearly
-25.81%
Q2 Forecast
148.88

Becton, Dickinson and Co. reported $44.54B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 168.02B 10.39B Apr/2026
Agilent USD 37.86B 3.64B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
AngioDynamics USD 511M 94M Sep/2025
Avanos Medical USD 521M 15M Dec/2025
Baxter International USD 9.82B 1.87B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Bio-Rad Laboratories USD 8.21B 601M Dec/2025
Boston Scientific USD 95.61B 2.35B Apr/2026
Cooper Companies USD 15.95B 2.05B Dec/2025
Danaher USD 140.45B 11.98B Apr/2026
Dentsply International USD 2.28B 251M Dec/2025
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 47.05B 884M Apr/2026
Globus Medical USD 11.69B 3.95B Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
Intuitive Surgical USD 159.96B 3.77B Apr/2026
J&J USD 561.65B 17.5B Apr/2026
Masimo USD 6.84B 839M Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
Thermo Fisher Scientific USD 177.96B 4.7B Apr/2026
WK Kellogg Co USD 13.74B 1.09B Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025